Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Vaccine|June 12, 2021
Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trialFrancisco Diaz-Mitoma, Vlad Popovic, Johanna N SpaansExpert Review of Vaccines|October 25, 2023
PreHevbrio: the first approved 3-antigen hepatitis B vaccineTimo Vesikari, Joanne M Langley, Vlad Popovic, et al.Vaccine|January 16, 2021
Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV studyJacob Atsmon, Nathalie Machluf, Vered Yayon-Gur, et al.The Lancet. Infectious Diseases|May 14, 2021
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trialTimo Vesikari, Joanne M Langley, Nathan Segall, et al.JAMA Network Open|October 12, 2021
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical TrialTimo Vesikari, Adam Finn, Pierre van Damme, et al.Pageof 1